Literature DB >> 27019337

Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score?

Hugo J A Adams1, Thomas C Kwee1.   

Abstract

Keywords:  International Harmonization Project; National Comprehensive Cancer Network International Prognostic Index; diffuse large B-cell lymphoma; fluorodeoxyglucose-positron emission tomography; response assessment

Mesh：

Substances：

Year:  2016        PMID： 27019337     DOI： 10.1111/bjh.14052

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma.

Authors:  Federico Fallanca; Pierpaolo Alongi; Elena Incerti; Luigi Gianolli; Maria Picchio; Irfan Kayani; Jamshed B Bomanji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-02       Impact factor: 9.236

2.  Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma.

Authors:  Hugo J A Adams; Thomas C Kwee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-25       Impact factor: 9.236

3.  PET-derived tumor metrics predict DLBCL response and progression-free survival.

Authors:  Prioty Islam; Jordan Goldstein; Christopher R Flowers
Journal:  Leuk Lymphoma       Date:  2019-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.